Fatty acid amide signaling molecules

doi:10.1016/j.bmcl.2010.08.048

Bioorganic & Medicinal Chemistry Letters

Volume 20, Issue 20, 15 October 2010, Pages 5959-5968

https://doi.org/10.1016/j.bmcl.2010.08.048 Get rights and content

Abstract

Key studies leading to the discovery and definition of the role of endogenous fatty acid amide signaling molecules are summarized.

Graphical abstract

Key studies leading to the discovery and role of endogenous fatty acid amide signaling molecules are summarized.

Section snippets

Acknowledgments

We gratefully acknowledge the financial support of the National Institutes of Health (DA015648) and the Skaggs Institute for Chemical Biology. K.O. is a Skaggs Fellow.

References and notes (159)

N.R. Bachur et al.
J. Biol. Chem.
(1965)
H. Cadas et al.
J. Neurosci.
(1996)
H. Cadas et al.
J. Neurosci.
(1997)
N.T. Snider et al.
J. Pharmacol. Exp. Ther.
(2007)
J. Axelrod et al.
Neurochem. Res.
(1998)
V. Di Marzo et al.
Lipids
(1999)
V. Di Marzo
Biochim. Biophys. Acta
(1998)
R. Mechoulam et al.
Eur. J. Pharmacol.
(1998)
V. Di Marzo et al.
Curr. Med. Chem.
(1999)
B.R. Martin et al.
Life Sci.
(1999)
V.M. Showalter et al.
J. Pharmacol. Exp. Ther.
(1996)
M. Seierstad et al.
J. Med. Chem.
(2008)
D.L. Boger et al.
Proc. Natl. Acad. Sci. U.S.A.
(2000)
D.L. Boger et al.
Bioorg. Med. Chem. Lett.
(2001)
D.L. Boger et al.
J. Med. Chem.
(2005)
D. Leung et al.
Bioorg. Med. Chem. Lett.
(2005)
F.A. Romero et al.
J. Am. Chem. Soc.
(2006)
F.A. Romero et al.
J. Med. Chem.
(2007)
C. Hardouin et al.
J. Med. Chem.
(2007)
F.S. Kimball et al.
J. Med. Chem.
(2008)
J. Garfunkle et al.
J. Med. Chem.
(2008)
J.K. DeMartino et al.
Bioorg. Med. Chem. Lett.
(2008)
M. Mileni et al.
J. Am. Chem. Soc.
(2009)
M. Mileni et al.
J. Med. Chem.
(2010)
(a)Brown, A. J.; Wise, A. Patent WO0186305,...(b)Drmota, E.; Greasley, P.; Groblewski, T. Patent WO2004074844,...A.J. Brown et al.
Vit. Hormones
(2009)
P.M. Zygmunt et al.
Nature
(1999)
D. Smart et al.
Br. J. Pharmacol.
(2000)
D. Smart et al.
Trends Pharmacol. Sci.
(2000)
Z. Olah et al.
J. Biol. Chem.
(2001)
L. De Petrocellis et al.
Proc. Natl. Acad. Sci. U.S.A.
(1998)

M.A.P. Meisinger et al.

J. Am. Chem. Soc.

(1957)

N. Ueda et al.

J. Biol. Chem.

(2001)

E. Berdyshev et al.

Life Sci.

(1998)

D.M. Lambert et al.

Epilepsia

(2001)

L. Hoareau et al.

Obesity

(2009)

H. Schuel et al.

Chem. Phys. Lipids

(2002)

X. Wang et al.

J. Physiol.

(2005)

J. Lo Verme et al.

J. Pharmacol. Exp. Ther.

(2006)

V. Di Marzo et al.

Biochem. J.

(1996)

L. Hanus et al.

J. Med. Chem.

(1993)

T. Bisogno et al.

Biochim. Biophys. Acta

(1997)

D.L. Boger et al.

Curr. Pharm. Des.

(1998)

R.A. Lerner et al.

Proc. Natl. Acad. Sci. U.S.A.

(1994)

J.E. Patterson et al.

J. Am. Chem. Soc.

(1996)

D.L. Boger et al.

Bioorg. Med. Chem. Lett.

(1999)

S. Huitron-Resendiz et al.

J. Exp. Neurol.

(2001)

S. Huitron-Resendiz et al.

Sleep

(2004)

B.J. Wilcox et al.

Biochemistry

(1999)

R. Mechoulam et al.

Nature

(1997)

I. Federova et al.

J. Pharmacol. Exp. Ther.

(2001)

A.S. Basile et al.

NeuroReport

(1999)

A.D. Laposky et al.

NeuroReport

(2001)

B. Verdon et al.

Br. J. Pharmacol.

(2000)

G. Less et al.

Br. J. Pharmacol.

(1998)

E.A. Thomas et al.

Proc. Natl. Acad. Sci. U.S.A.

(1997)

W.A. Devane et al.

Mol. Pharmacol.

(1988)

L.A. Matsuda et al.

Nature

(1990)

S. Munro et al.

Nature

(1993)

W.A. Devane et al.

Science

(1992)

Y. Okamoto et al.

Chem. Biodiv.

(2007)

V. Natarajan et al.

Biochim. Biophys. Acta

(1982)

P.C. Schmid et al.

J. Biol. Chem.

(1983)

K. Ahn et al.

Chem. Rev.

(2008)

V. Di Marzo et al.

Nature

(1994)

D. Leung et al.

Biochemistry

(2006)

V. Natarajan et al.

J. Neurochem.

(1984)

G.M. Simon et al.

J. Biol. Chem.

(2006)

G.M. Simon et al.

J. Biol. Chem.

(2008)

J. Liu et al.

Proc. Natl. Acad. Sci. U.S.A.

(2006)

J. Liu et al.

Neuropharmacology

(2008)

B.F. Cravatt et al.

Nature

(1996)

D.L. Boger et al.

Bioorg. Med. Chem. Lett.

(2000)

C.J. Fowler et al.

Biochem. Pharmacol.

(2001)

M. Kaczocha et al.

J. Biol. Chem.

(2006)

T.A. Day et al.

Mol. Pharmacol.

(2001)

D.K. Giang et al.

Proc. Natl. Acad. Sci. U.S.A.

(1997)

I.B. Adams et al.

J. Pharmacol. Exp. Ther.

(1995)

R.G. Pertwee

Curr. Med. Chem.

(1999)

A. Calignano et al.

Nature

(1998)

J.M. Walker et al.

Proc. Natl. Acad. Sci. U.S.A.

(1999)

S. Gaetani et al.

Trends Mol. Med.

(2004)

B.F. Cravatt et al.

Proc. Natl. Acad. Sci. U.S.A.

(2004)

F. Massa et al.

J. Clin. Invest.

(2004)

D.M. Lambert et al.

Curr. Med. Chem.

(2002)

F. Rodriguez de Fonseca et al.

Nature

(2001)

Cited by (121)

Polyquaternium polymers cause inflammatory response and alterations of the lipidome in Danio rerio larvae
2024, Journal of Hazardous Materials Letters
Polyquaternium polymers are widely used in various applications, such as personal care products and wastewater treatment plants, and eventually end up in the aquatic environment. While polymers have been perceived of low toxicological concern due to their size, several studies have pointed towards water-soluble cationic polymers being toxic towards aquatic organisms – and that the toxicity largely is determined by the polymer charge density. The present study investigated the polyquaternium toxicological mechanism of action throughout lipidomic analysis and changes in immune-gene expression (qPCR) of zebrafish larvae exposed continuously to two water-soluble polymers; a high charge density polyquaternium-6 and a low charge density polyquaternium-10, for 5 and 12 days upon fertilization. The results showed that the investigated polyquaterniums cause both inflammatory responses and significant alterations of the zebrafish larvae lipidome. Depending on polyquaternium polymer and larvae development stage, the gene expression showed an inflammatory response (e.g. significant up-regulation of il8, il1β and tnfα) in the exposed zebrafish. Alterations of the lipidome were additionally observed, with severe depletion of lipids (e.g. lyso-glycerophosphocholines and ceramides) in the 12 days old larvae exposed to high charge density polymer. The findings furthermore support a hypothetical mechanism of action to be non-specific and lethality potentially to be narcosis-like driven.
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models
2022, Biomedicine and Pharmacotherapy
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer. The characteristic excessive stromatogenesis accompanying the growth of this tumor is believed to contribute to chemoresistance which, together with drug toxicity, results in poor clinical outcome. An increasing number of studies are showing that gut microbiota and their metabolites are implicated in cancer pathogenesis, progression and response to therapies. In this study we tested butyrate, a product of dietary fibers’ bacterial fermentation, whose anticancer and anti-inflammatory functions are known. We provided in vitro evidence that, beside slowing proliferation, butyrate enhanced gemcitabine effectiveness against two human pancreatic cancer cell lines, mainly inducing apoptosis. In addition, we observed that, when administered to a PDAC mouse model, alone or combined with gemcitabine treatment, butyrate markedly reduced the cancer-associated stromatogenesis, preserved intestinal mucosa integrity and affected fecal microbiota composition by increasing short chain fatty acids producing bacteria and decreasing some pro-inflammatory microorganisms. Furthermore, a biochemical serum analysis showed butyrate to ameliorate some markers of kidney and liver damage, whereas a metabolomics approach revealed a deep modification of lipid metabolism, which may affect tumor progression or response to therapy. Such results support that butyrate supplementation, in addition to conventional therapies, can interfere with pancreatic cancer biology and response to treatment and can alleviate some damages associated to cancer itself or to chemotherapy.
Biodegradation of expanded polystyrene by mealworm larvae under different feeding strategies evaluated by metabolic profiling using GC-TOF-MS
2021, Chemosphere
The present study investigated the biodegradation of polystyrene (PS) plastic by mealworm (Tenebrio molitor) on different diets followed by untargeted screening of larvae gut intestine tissue and frass (manure and feed residuals) to investigate the existence of polymer-generated organic residues. Three different diets, consisting of PS, rolled barley and water were tested. PS degradation rates ranged from 16% to 23% within 15 days, with no statistical differences in survival rates. The larvae fed with ad libitum barley:PS (20:1 w/w) and water had the highest growth rate, while higher PS consumption was observed for barley:PS of 4:1 w/w. A GC-TOF-MS analysis revealed no contaminating substances in the gut intestine tissue, nor styrene or PS oligomers, whilst several bioactive compounds and traces of alkanes, mostly with small carbon chains, were present. Metabolomics analysis on the collected frass, either on the lipophilic (CHCl₃) or the polar fraction (MeOH–H₂O) was performed. Styrene and PS oligomers (dimers, trimers) were identified, though in a relatively low total amount, up to a total of 346.0 ng/mg 2,4 di-tert butylphenol was identified in both frass and tissue, coming from the PS polymer (Non-intentionally added substances; NIAS). Finally, in the polar fraction of frass, bioactive molecules (fatty acids, amides) were identified, together with several hydrocarbons, mostly with longer carbon chains. The formation of these substances indicated enzymatic and biochemical activity in the larvae-gut intestine. It was shown that degrading and contaminating organic compounds occur at low levels, in both gut intestine and frass, during bio-degradation of PS.
Artocarpus integrifolia seed lectin enhances membrane damage, oxidative stress and biofilm inhibition activity of silver nanoparticles against Staphylococcus aureus
2021, Colloids and Surfaces A: Physicochemical and Engineering Aspects
Functionalizing the nanoparticles to target the bacteria surface is an effective approach to curb drug resistance pathogens. The present study describes the synthesis of N-myristoyltaurine capped silver nanoparticles (AgNPs) and functionalization of AgNPs with jacalin (JAgNPs), a lectin from the seeds of Artocarpus integrifolia. JAgNPs has fourfold lower minimum inhibitory concentration than AgNPs and kills the S. aureus in less than 30 min through inducing oxidative stress and membrane damage. JAgNPs (31.25 µM) was found to have excellent biofilm inhibitory activity at lower concentration than AgNPs (62.5 µM). This was judged by crystal violet assay, light microscopy imaging and confocal laser scanning microscopy (CLSM) method. CLSM analysis reveals that JAgNPs is highly effective as compared to AgNPs in reducing the bio-volume and average biofilm thickness to 18.3 ± 2.5 µm³/µm² and 14.0 ± 2.6 µm, respectively. Scanning electron microscopy (SEM) study reveals that JAgNPs prevents the colony formation and inhibited exopolysaccharide synthesis, thereby reducing the formation of biofilm. At minimum biofilm inhibitory concentrations, SEM and double staining technique using CLSM provides evidence that cells are intact and live, suggesting that NPs exhibit true biofilm activity. The findings indicate that jacalin functionalization may offer a unique way to use nanosilver at lower concentrations for treating infection associated with S. aureus biofilm.
A novel method for oil deacidification: Chemical amidation with ethanolamine catalyzed by calcium oxide
2021, LWT
Deacidification is an essential process to reduce free fatty acids (FFA) to an acceptable level for edible oils before entering the market. In this study, we investigated the feasibility of using ethanolamine as substrate to reduce acidity of high-acid rice bran oil (HRBO). The preliminary study showed that the best catalyst for the amidation was calcium oxide. Afterwards, optimization of reaction conditions was conducted. Under the optimized conditions, the deacidified RBO contained 1.1% FFA. Results also demonstrated that value-added products fatty ethanolamides were formed in the amidation reaction, which may greatly reduce the costs for deacidification process. This study indicated that the novel pretreatment method using calcium oxide as catalyst to reduce FFA is effective, economical and environmentally friendly.
Lipid metabolism and lipid signals in aging and longevity
2021, Developmental Cell
Lipids play crucial roles in regulating aging and longevity. In the past few decades, a series of genetic pathways have been discovered to regulate lifespan in model organisms. Interestingly, many of these regulatory pathways are linked to lipid metabolism and lipid signaling. Lipid metabolic enzymes undergo significant changes during aging and are regulated by different longevity pathways. Lipids also actively modulate lifespan and health span as signaling molecules. In this review, we summarize recent insights into the roles of lipid metabolism and lipid signaling in aging and discuss lipid-related interventions in promoting longevity.

View all citing articles on Scopus

View full text

BMCL DigestFatty acid amide signaling molecules

Abstract

Graphical abstract

Section snippets

Acknowledgments

J. Biol. Chem.

J. Neurosci.

J. Neurosci.

J. Pharmacol. Exp. Ther.

Neurochem. Res.

Lipids

Biochim. Biophys. Acta

Eur. J. Pharmacol.

Curr. Med. Chem.

Life Sci.

J. Pharmacol. Exp. Ther.

J. Med. Chem.

Proc. Natl. Acad. Sci. U.S.A.

Bioorg. Med. Chem. Lett.

J. Med. Chem.

Bioorg. Med. Chem. Lett.

J. Am. Chem. Soc.

J. Med. Chem.

J. Med. Chem.

J. Med. Chem.

J. Med. Chem.

Bioorg. Med. Chem. Lett.

J. Am. Chem. Soc.

J. Med. Chem.

Vit. Hormones

Nature

Br. J. Pharmacol.

Trends Pharmacol. Sci.

J. Biol. Chem.

Proc. Natl. Acad. Sci. U.S.A.

J. Am. Chem. Soc.

J. Biol. Chem.

Life Sci.

Epilepsia

Obesity

Chem. Phys. Lipids

J. Physiol.

J. Pharmacol. Exp. Ther.

Biochem. J.

J. Med. Chem.

Biochim. Biophys. Acta

Curr. Pharm. Des.

Proc. Natl. Acad. Sci. U.S.A.

J. Am. Chem. Soc.

Bioorg. Med. Chem. Lett.

J. Exp. Neurol.

Sleep

Biochemistry

Nature

J. Pharmacol. Exp. Ther.

NeuroReport

NeuroReport

Br. J. Pharmacol.

Br. J. Pharmacol.

Proc. Natl. Acad. Sci. U.S.A.

Mol. Pharmacol.

Nature

Nature

Science

Chem. Biodiv.

Biochim. Biophys. Acta

J. Biol. Chem.

Chem. Rev.

Nature

Biochemistry

J. Neurochem.

J. Biol. Chem.

J. Biol. Chem.

Proc. Natl. Acad. Sci. U.S.A.

Neuropharmacology

Nature

Bioorg. Med. Chem. Lett.

Biochem. Pharmacol.

J. Biol. Chem.

Mol. Pharmacol.

BMCL Digest
Fatty acid amide signaling molecules